These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Photodistributed eruptive telangiectasia: an uncommon adverse drug reaction to venlafaxine. Vaccaro M; Borgia F; Barbuzza O; Guarneri B Br J Dermatol; 2007 Oct; 157(4):822-4. PubMed ID: 17655739 [No Abstract] [Full Text] [Related]
12. Withdrawal and rebound symptoms associated with abrupt discontinuation of venlafaxine. Dallal A; Chouinard G J Clin Psychopharmacol; 1998 Aug; 18(4):343-4. PubMed ID: 9690703 [No Abstract] [Full Text] [Related]
13. An acute ischaemic event associated with the use of venlafaxine: a case report and proposed pathophysiological mechanisms. Reznik I; Rosen Y; Rosen B J Psychopharmacol; 1999; 13(2):193-5. PubMed ID: 10475726 [TBL] [Abstract][Full Text] [Related]
14. Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Chial HJ; Camilleri M; Ferber I; Delgado-Aros S; Burton D; McKinzie S; Zinsmeister AR Clin Gastroenterol Hepatol; 2003 May; 1(3):211-8. PubMed ID: 15017493 [TBL] [Abstract][Full Text] [Related]
16. Severe anticholinergic side effects with venlafaxine-fluoxetine combination. Benazzi F Can J Psychiatry; 1997 Nov; 42(9):980-1. PubMed ID: 9429070 [No Abstract] [Full Text] [Related]
17. Venlafaxine-related akathisia side-effects and management in a depressed patient. Lai CH Psychiatry Clin Neurosci; 2013 Feb; 67(2):127-8. PubMed ID: 23438168 [No Abstract] [Full Text] [Related]